AKT1 and liver cancer: To test if the activation of Akt and Rac1 was involved in hypoxia-induced upregulation of Fascin-1, we used EHop-016 (Rac1 inhibitor) and MK-2206 (Akt inhibitor) to suppress Akt and Rac1 activation in liver cancer cells.